Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyodine Soaked Gelfoam vs Clotrimazole for Otomycosis
NCT06339294Phase 1Completed
- Sponsor
- Rawalpindi Medical University
- Start
- Jun 2023
- Primary completion
- Dec 2023
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of IVIEW-1502 in otomycosis (2 arms), sponsored by Rawalpindi Medical University. Primary endpoint: Treatment Response Based on Otoscopy at 14 days. Started Jun 2023; status: completed.
02
Drugs
IVIEW-1502
03
Conditions
otomycosis
Beyond the preview
Go deeper on NCT06339294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06339294.